Hospital COVID-19 Burden Impacted NSTEMI Treatment, Outcome
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 30, 2023 -- For patients with non-ST segment elevation myocardial infarction (NSTEMI), hospital COVID-19 burden was associated with worse outcomes and treatments but did not affect race and ethnicity-associated inequities, according to a study published online Aug. 25 in JAMA Network Open.
Laurent G. Glance, M.D., from the University of Rochester School of Medicine in New York, and colleagues conducted a cross-sectional study to examine whether the COVID-19 pandemic was associated with increased disparities in treatment and outcomes among Medicare patients hospitalized with acute MI (AMI) between January 2016 and November 2020.
Data were included for 1,319,273 admissions for AMI (9.3, 8.9, and 81.8 percent Black, Hispanic, and White, respectively). The researchers found that for patients hospitalized during weeks with a high COVID-19 burden (>30 percent) in the hospital, the adjusted odds of mortality and nonhome discharges increased significantly for patients with NSTEMI overall (adjusted odds ratios [OR], 1.51 and 1.32, respectively), and odds of revascularization decreased (adjusted OR, 0.73) compared with patients hospitalized before the pandemic. For each 10 percent increase in COVID-19 hospital burden, Black versus White individuals with NSTEMI had a clinically insignificant increase in the odds of mortality (adjusted OR, 1.07) but no increases in readmissions or nonhome discharges or decrease in revascularizations. No differential increases were seen in adverse outcomes among Hispanic versus White patients with NSTEMI based on hospital COVID-19 burden.
"Policy and clinical interventions are needed to ensure that hospitals can continue to provide high-quality, evidence-based care for all patients, even in times of strain or stress," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
Pediatric Resource Use Less Likely With Legalization of Recreational Cannabis
WEDNESDAY, May 1, 2024 -- In cases of cannabis intoxication in children, resource utilization is less likely in states with recreational legalization of cannabis, according to a...
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Osteoporosis Screening Rates Low for Asian American Medicare Beneficiaries
WEDNESDAY, May 1, 2024 -- Rates of dual-energy X-ray absorptiometry (DXA) screening for osteoporosis are lower than expected for Asian American Medicare beneficiaries, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.